TY  - JOUR 
AU  - Gaibar, Maria
AU  - Novillo, Apolonia
AU  - Romero, Alicia
AU  - Fernandez, Ana
AU  - Malon, Diego
AU  - Anton, Beatriz
AU  - Moreno, Amalia
PY  - 2023
UR  - http://hdl.handle.net/20.500.12020/985
AB  - The addition to chemotherapy of anti-HER2 drugs such as trastuzumab or pertuzumab has
improved outcomes in HER2-positive breast cancer patients. However, resistance to these drugs in
some patients remains a major concern. This study examines the...
LA  - en
PB  - MDPI
TI  - HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
DO  - https://doi.org/10.3390/cancers15030763
T2  - Cancers
M2  - -
KW  - HER2-positive breast cancer; anti-HER2 treatment; HER2 gene; SNPs; pathological complete response; Miller–Payne grading
VL  - 15
ER  -